Abstract
The upregulatory mechanism of cellular NF-κB activity by carcinogens, N-nitroso-N-methylurea (NMU) and N-nitroso-N-ethylurea (NEU) in human malignant keratinocytes was investigated. To elucidate the role of protein kinase C (PKC) in the upregulation of NF-κB by NMU and NEU, two known PKC inhibitors, staurosporine and H-7 were studied. Treatment of cells with PKC inhibitors decreased NF-κB activity in a dose responsive manner at concentrations of 20∼200 nM. Staurosporine (160 nM) and H-7 (200 nM) downregulated the cellular NF-κB activation up to 20 and 60% compared to the NF-κB activity that was upregulated by NMU (5 μM) and NEU (5 μM), respectively. These results indicated that the PKC activity was responsible for the upregulation of NF-κB activity. The level of phosphorylation of I-κBα, the predominant form of the I-κB family represented by NMU and NEU, was quantified. The relative amount of I-κBα phosphorylation (serines-32 and -36) determined using the cellular activation of signaling ELISA assay method showed that NMU (5 μM) and NEU (5 μM) increased the amount of I-κBα phosphorylation up to 17 and 10% compared to the control, respectively. The results demonstrate the upregulatory effect of NMU and NEU on cellular NF-κB activity in human keratinocytes via the protein kinase C-mediated pathway.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baeuerle, P. A., The inducible transcription factor NF-κB-regulation by distinct protein subunits. Biochim. Biophys. Acta, 1072, 63–80 (1991).
Baeuerle, P. A. and Baltimore, D., I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science, 242, 540–546 (1988).
Baldwin, A. S., The NF-kappa-B and I-kappa-B proteins-New discoveries and insights. Annu. Rev. Immunol., 14, 649–683 (1996).
Bomsztyk, K., Rooney, J. W., Iwasaki, T., Rachie, N. A., Dower, S. K., and Sibley, C. H., Evidence that interleukin-1 and phorbol esters activate NF-κB by different pathways: role of protein kinase C. Cell Regul., 2, 329–335 (1991).
Bours, V., Bentires-Alj, M., Hellin, A.-C., Viatour, P., Robe, P., Delhalle, S., Benoit, V., and Merville, M.-P., Nuclear factor-κB, cancer, and apoptosis. Biochem. Pharmacol., 60, 1085–1090 (2000).
Bours, V., Dejardin, E., Goujon-Letawe, F., Merville, M. P., and Castronovo, V., The NF-kappa B transcription factor and cancer: high expression of NF-kappa B-and I kappa B-relared proteins in tumor cell lines. Biochem. Pharmacol., 47, 145–149 (1994).
Chen, F. C., Huang, D. -B., Chen, Y. -Q., and Ghosh, G., Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA. Nature, 391, 410–413 (1998).
Darnell, Jr., J. E., Transcription factors as targets for cancer therapy. Nat. Rev., 2, 740–749 (2002).
Garg, A. and Aggarwal, B. B., Nuclear transcription factor-κB as a target for cancer drug development. Leukemia, 16, 1053–1068 (2002).
Ghosh, S. and Baltimore, D., Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature, 344, 678–682 (1990).
Grimm, S. and Baeuerle, P. A., The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Biochem. J., 290(Pt 2), 297–308 (1993).
Hellin, A-C., Bentires-Alj, M., Verlaet, M., Benoit, V., Gielen, J., Bours, V., and Merville, M-P., Roles of nuclear factor-κB, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosis. J. Pharmacol. Exp. Ther., 295, 870–878 (2000).
Hidaka, H., Inagaki, M., Kawamoto, S., and Sasaki, Y., Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry, 23, 5036–5041 (1984).
Huxford, T., Huang, D. B., Malek, S., and Ghosh, G., The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappa B inactivation. Cell, 95, 759–770 (1998).
Lallena, M-J., Diaz-Meco, M. T., Bren, G., Paya, C. V., and Moscat, J., Activation of IκB kinase b by protein kinase C isoforms. Mol. Cell Biol., 19, 2180–2188 (1999).
Legrand-Poels, S., Schoonbroodt, S., Matroule, J.-Y., and Piette, J., NF-κB: an important transcription factor in photobiology. J. Photochem. Photobiol. B, Biol., 45, 1–8 (1998).
Legrand-Poels, S., Zecchinon, L., Piret, B., Schoonbroodt, S., and Piette, J., Involvement of different transduction pathways in NF-κB activation by several inducers. Free Rad. Res., 27, 301–309 (1997).
Li, Y. Q., Fan, C. Y., O’Connor, P. J., Winton, D. J., and Potten, C. S., Target cells for the cytotoxic effects of carcinogens in the murine small bowel. Carcinogenesis, 13, 361–368 (1992).
Likhachev, A. J., Ivanov, M. N., Bresil, H., Planche-Martel, G., Montesano, R., and Margison, G. P., Carcinogenicity of single doses of N-nitroso-N-methylurea and N-nitroso-Nethylurea in Syrian golden hamsters and the persistence of alkylated purines in the DNA of various tissues. Cancer Res., 43, 829–833 (1983).
Meichle, A., Schutze, S., Hensel, G., Brunsing, D., and Kronket, M., Protein kinase C-independent activation of nuclear factor κB by tumor necrosis factor. J. Biol. Chem., 265, 8339–8343 (1990).
Moon K. -Y., The chemopreventive effect of retinoids on cellular NF-κB activity induced by NMU and NEU in human malignant keratinocytes. Cancer Res. Treat., 39, 82–87 (2007).
Moon K.-Y., Hahn B.-S., Lee J., and Kim Y. S., A cell-based assay system for monitoring NF-κB activity in human HaCaT transfectant cells. Anal. Biochem., 292, 17–21 (2001).
Moon, K.-Y., Lee, Y. J., and Kim, Y. S., Upregulation of cellular NF-κB activity by alkylating carcinogens in human epidermal keratinocytes. Biol. Pharm. Bull., 26, 1195–1197 (2003).
Nakamura, T., Ushijima, T., Ishizaka, Y., Nagao, M., Nemoto, T., Hara, M., and Ishikawa, T., Neu proto-oncogene mutation is specific for the neurofibromas in a N-nitroso-N-ethylurea-induced hamster neurofibromatosis model but not for hamster melanomas and human Schwann cell tumors. Cancer Res., 54, 976–980 (1994).
Németh, Z. H., Wong, H. R., Odoms, K., Deitch, E. A., Szabó, C., Vizi, E. S., and Haskó, G., Proteasome inhibitors induce inhibitory κB (IκB) kinase activation, IκBα degradation, and nuclear factor κB activation in HT-29 cells. Mol. Pharmacol., 65, 342–349 (2004).
Rayet, B. and Gelinas, C., Aberrant rel/nfkb genes and activity in human cancer. Oncogene, 18, 6938–6947 (1999).
Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monks, A., Tierney, S., Nofziger, T. H., Currens, M. J., Seniff, D., and Boyd, M. R., Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res., 48, 4827–4833 (1988).
Siebenlist, U., Franzoso, G., and Brown, K., Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol., 10, 405–455 (1994).
Sukumar, S., Notario, V., Martin-Zanca, D., and Barbacid, M., Induction of mammary carcinomas in rats by nitrosomethylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature, 306, 658–661 (1983).
Tamaoki, T., Nomoto, H., Takahashi, I., Kato, Y., Morimoto, M., and Tomita, F., Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem. Biophy. Res. Commun., 135, 397–402 (1986).
Versteeg, H. H., Nijhuis, E., van den Brink G. R., Evertzen, M., Pynaert, G. N., van Deventer, S. J., Coffer, P. J., and Peppelenbosch, M. P., A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMPresponse-element-binding protein. Biochem. J., 350, 717–722 (2000).
Vertegaal, A. C. O., Kuiperij, H. B., Yamaoka, S., Courtois, G., van der Eb, A. J., and Zantema, A., Protein kinase C-α is an upstream activator of the IκB kinase complex in the TPA signal transduction pathway to NF-κB in U20S cells. Cell. Signal., 12, 759–768 (2000).
Zarbl, H., Sukumar, S., Arthur, A. V., Martin-Zanca, D., and Barbacid, M., Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature, 315, 382–385 (1985).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moon, KY. N-nitroso-N-methylurea and N-nitroso-N-ethylurea induce upregulation of cellular NF-κ B activity through protein kinase C-dependent pathway in human malignant keratinocytes. Arch. Pharm. Res. 33, 133–139 (2010). https://doi.org/10.1007/s12272-010-2235-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-2235-5